{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:36:08Z","timestamp":1740123368476,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["SAC100008","SAB160001"],"award-info":[{"award-number":["SAC100008","SAB160001"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF-21-124"],"award-info":[{"award-number":["BCRF-21-124"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10549-024-07510-8","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:03:39Z","timestamp":1729519419000},"page":"513-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive breast cancer"],"prefix":"10.1007","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-6385","authenticated-orcid":false,"given":"Shoshana M.","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katheryn","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh Wallace","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Snow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa E.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy U.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric P.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"7510_CR1","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF, Ebctcg (2017) 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med 377:1836\u20131846. https:\/\/doi.org\/10.1056\/NEJMoa1701830","journal-title":"N Engl J Med"},{"key":"7510_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/jnci\/djab202","volume":"114","author":"RN Pedersen","year":"2022","unstructured":"Pedersen RN, Esen BO, Mellemkjaer L, Christiansen P, Ejlertsen B, Lash TL, Norgaard M, Cronin-Fenton D (2022) The incidence of breast cancer recurrence 10\u201332 years after primary diagnosis. J Natl Cancer Inst 114:391\u2013399. https:\/\/doi.org\/10.1093\/jnci\/djab202","journal-title":"J Natl Cancer Inst"},{"key":"7510_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/jnci\/djx134","volume":"110","author":"EJ Blok","year":"2018","unstructured":"Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, van den Bosch J, Maartense E, van Leeuwen-Stok AE, Liefers GJ, Nortier JWR, Rutgers EJT, van de Velde CJH, Group IS (2018) Optimal duration of extended adjuvant endocrine therapy for early breast cancer; results of the IDEAL trial (BOOG 2006\u201305). J Natl Cancer Inst 110:40\u201348. https:\/\/doi.org\/10.1093\/jnci\/djx134","journal-title":"J Natl Cancer Inst"},{"key":"7510_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1604700","volume":"375","author":"PE Goss","year":"2016","unstructured":"Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR (2016) Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med 375:209\u2013219. https:\/\/doi.org\/10.1056\/NEJMoa1604700","journal-title":"N Engl J Med"},{"key":"7510_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(18)30621-1","volume":"20","author":"EP Mamounas","year":"2019","unstructured":"Mamounas EP, Bandos H, Lembersky BC, Jeong JH, Geyer CE Jr, Rastogi P, Fehrenbacher L, Graham ML, Chia SK, Brufsky AM, Walshe JM, Soori GS, Dakhil SR, Seay TE, Wade JL 3rd, McCarron EC, Paik S, Swain SM, Wickerham DL, Wolmark N (2019) Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology\/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 20:88\u201399. https:\/\/doi.org\/10.1016\/S1470-2045(18)30621-1","journal-title":"Lancet Oncol"},{"key":"7510_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D (2009) Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res 18:873\u2013880. https:\/\/doi.org\/10.1007\/s11136-009-9496-9","journal-title":"Qual Life Res"},{"key":"7510_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","volume":"60","author":"E Broadbent","year":"2006","unstructured":"Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60:631\u2013637. https:\/\/doi.org\/10.1016\/j.jpsychores.2005.10.020","journal-title":"J Psychosom Res"},{"key":"7510_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/bjhp.12003","volume":"18","author":"AL Corter","year":"2013","unstructured":"Corter AL, Findlay M, Broom R, Porter D, Petrie KJ (2013) Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer. Br J Health Psychol 18:168\u2013181. https:\/\/doi.org\/10.1111\/bjhp.12003","journal-title":"Br J Health Psychol"},{"key":"7510_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jnci\/djn010","volume":"100","author":"A Partridge","year":"2008","unstructured":"Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100:243\u2013251","journal-title":"J Natl Cancer Inst"},{"key":"7510_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10549-016-4082-7","volume":"161","author":"ST Hawley","year":"2017","unstructured":"Hawley ST, Janz NK, Griffith KA, Jagsi R, Friese CR, Kurian AW, Hamilton AS, Ward KC, Morrow M, Wallner LP, Katz SJ (2017) Recurrence risk perception and quality of life following treatment of breast cancer. Breast Cancer Res Treat 161:557\u2013565. https:\/\/doi.org\/10.1007\/s10549-016-4082-7","journal-title":"Breast Cancer Res Treat"},{"key":"7510_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1472-6947-12-51","volume":"12","author":"KR Sepucha","year":"2012","unstructured":"Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, Partridge A, Lee CN (2012) Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak 12:51. https:\/\/doi.org\/10.1186\/1472-6947-12-51","journal-title":"BMC Med Inform Decis Mak"},{"key":"7510_CR12","doi-asserted-by":"publisher","first-page":"e53607","DOI":"10.1371\/journal.pone.0053607","volume":"8","author":"SC O\u2019Neill","year":"2013","unstructured":"O\u2019Neill SC, DeFrank JT, Vegella P, Richman AR, Henry LR, Carey LA, Brewer NT (2013) Engaging in health behaviors to lower risk for breast cancer recurrence. PLoS One 8:e53607. https:\/\/doi.org\/10.1371\/journal.pone.0053607","journal-title":"PLoS One"},{"key":"7510_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10549-019-05182-3","volume":"175","author":"K Kaiser","year":"2019","unstructured":"Kaiser K, Cameron KA, Beaumont J, Garcia SF, Lacson L, Moran M, Karavites L, Rodgers C, Kulkarni S, Hansen NM, Khan SA (2019) What does risk of future cancer mean to breast cancer patients? Breast Cancer Res Treat 175:579\u2013584. https:\/\/doi.org\/10.1007\/s10549-019-05182-3","journal-title":"Breast Cancer Res Treat"},{"key":"7510_CR14","doi-asserted-by":"publisher","first-page":"117-125","DOI":"10.1007\/s10549-022-06684-3","volume":"195","author":"JW Ankersmid","year":"2022","unstructured":"Ankersmid JW, Lansink Rotgerink FK, Strobbe LJA, van Uden-Kraan CF, Siesling S, Drossaert CHC (2022) Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors. Breast Cancer Res Treat 195:117\u2013125. https:\/\/doi.org\/10.1007\/s10549-022-06684-3","journal-title":"Breast Cancer Res Treat"},{"key":"7510_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1634\/theoncologist.2012-0376","volume":"18","author":"KJ Ruddy","year":"2013","unstructured":"Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP, Partridge AH (2013) Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist 18:362\u2013368. https:\/\/doi.org\/10.1634\/theoncologist.2012-0376","journal-title":"Oncologist"},{"key":"7510_CR16","doi-asserted-by":"publisher","first-page":"pkz080","DOI":"10.1093\/jncics\/pkz080","volume":"4","author":"CM Friedenreich","year":"2020","unstructured":"Friedenreich CM, Stone CR, Cheung WY, Hayes SC (2020) Physical activity and mortality in cancer survivors: a systematic review and meta-analysis. JNCI Cancer Spectr 4:pkz080. https:\/\/doi.org\/10.1093\/jncics\/pkz080","journal-title":"JNCI Cancer Spectr"},{"key":"7510_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41523-020-0149-z","volume":"6","author":"PJ Goodwin","year":"2020","unstructured":"Goodwin PJ, Segal RJ, Vallis M, Ligibel JA, Pond GR, Robidoux A, Findlay B, Gralow JR, Mukherjee SD, Levine M, Pritchard KI (2020) The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer. NPJ Breast Cancer 6:6. https:\/\/doi.org\/10.1038\/s41523-020-0149-z","journal-title":"NPJ Breast Cancer"},{"key":"7510_CR19","unstructured":"World Cancer Research Fund International\/American Institute for Cancer Research. Continuous update project: diet, nutrition, physical activity and the prevention of cancer. summary of strong evidence. Available at: wcrf.org\/cupmatrix. Accessed 25 May 2023"},{"key":"7510_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41523-017-0040-8","volume":"3","author":"JA Ligibel","year":"2017","unstructured":"Ligibel JA, Barry WT, Alfano C, Hershman DL, Irwin M, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, Hahn O, Hudis C, Winer EP, Wadden TA, Goodwin PJ (2017) Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. NPJ Breast Cancer 3:37. https:\/\/doi.org\/10.1038\/s41523-017-0040-8","journal-title":"NPJ Breast Cancer"},{"key":"7510_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/1055-9965.EPI-12-1022","volume":"22","author":"ML Kwan","year":"2013","unstructured":"Kwan ML, Chen WY, Flatt SW, Weltzien EK, Nechuta SJ, Poole EM, Holmes MD, Patterson RE, Shu XO, Pierce JP, Caan BJ (2013) Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev 22:32\u201341. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7510_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","volume":"34","author":"CD Runowicz","year":"2016","unstructured":"Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34:611\u2013635. https:\/\/doi.org\/10.1200\/JCO.2015.64.3809","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07510-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:42:58Z","timestamp":1738356178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07510-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7510"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07510-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SM Rosenberg: grant funding from Pfizer Global Medical Grants\/Conquer Cancer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the IRB. The study was approved by the Dana-Farber Cancer Institute Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individuals included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}